Accuri C6 Flow Cytometer System
A more recent version of this article appeared on July 1, 2009

Published online before print April 23, 2009
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0608363v1
86/1/187    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tang, C.
Right arrow Articles by Yoshikai, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tang, C.
Right arrow Articles by Yoshikai, Y.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0608363

Received for publication June 18, 2008.
Revised February 17, 2009.
Accepted for publication March 5, 2009.

Article

IL-15 protects antigen-specific CD8+ T cell contraction after Mycobacterium bovis bacillus Calmette-Guérin infection

Ce Tang *, Hisakata Yamada *, Kensuke Shibata *, Shin-ichi Yoshida {dagger}, Worawidh Wajjwalku {ddagger}, and Yasunobu Yoshikai *@

*Division of Host Defense, Medical Institute of Bioregulation, and{dagger}Department of Bacteriology, Kyushu University, Fukuoka, Japan; and{ddagger}Department of Pathology, Faculty of Veterinary Medicine, Kasetsart University, Nakhonpathom, Thailand

@ To whom correspondence should be addressed. E-mail: yoshikai{at}bioreg.kyushu-u.ac.jp.


arrow
Abstract

We reported previously that IL-15 plays a critical role in protecting effector CD8+ T cells from apoptosis during the contraction phase following acute infection with Listeria monocytogenes by inducing antiapoptotic molecules. In the present study, we examined the effects of in vivo administration of rIL-15 on contraction of CD8+ T cells after chronic infection with Mycobacterium bovis BCG and on the efficacy of BCG vaccination against Mycobacterium tuberculosis infection. Antigen-specific CD8+ T cells reached an expansion peak at approximately Day 21, followed by a contraction after inoculation with rBCG expressing OVA. In vivo administration of rIL-15 from Days 22 to 42 after BCG inoculation inhibited apoptosis of effector CD8+ T cells by up-regulating their Bcl-2 expression, resulting in a significant increase of antigen-specific memory CD8+ T cells producing IFN-{gamma}. However, the IL-15 treatment did not elicit improved efficacy of BCG vaccination against M. tuberculosis. These results suggest that IL-15 plays a critical role in protecting activated CD8+ T cells from apoptosis during the contraction phase following BCG inoculation, although IL-15 administration alone at the contraction phase might not be sufficient to protect the efficient memory T cell responses against subsequent infection with M. tuberculosis.

Key Words: bacterial • apoptosis • memory • OVA




This article has been cited by other articles:


Home page
 JEMHome page
T. D. Randall
Pulmonary dendritic cells: thinking globally, acting locally
J. Exp. Med., March 15, 2010; 207(3): 451 - 454.
[Abstract] [Full Text] [PDF]